OPTR Fighting Weak Dificid Trends With Price Reduction, Estimates Going Down
This is what I have been saying all along. Most Longs on this board are clueless, not to mention OPTR management. Do they honestly believe a 25% reduction is going to dramatically change the cost/benefit? FIDo is simply not competitive enough. Yikes another quarter of poor sales, just a matter of time before the tidal wave of institutional selling begins and realizes what a POS OPTR really is.....See you at 7pps!
Lowering In-hospital cost is great way to grow actually. Doctor know it's great drug they just get hammer by pharmacist. When come to hospital sale, pharmacist is bigger hurdle. They look at cost than benefit (Or even Cost/benefit equation). Lowering cost for hospital make them resist less.